Medcath Corp - Securities Registration: Employee Benefit Plan (S-8)
June 11 2008 - 9:04AM
Edgar (US Regulatory)
As
filed with the Securities and Exchange Commission on June 11, 2008
Registration No. 333-________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION OF SECURITIES UNDER THE SECURITIES ACT OF 1933
MedCath Corporation
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
|
56-2249852
(I.R.S. Employer
Identification No.)
|
|
|
|
10720 Sikes Place, Suite 300
Charlotte, North Carolina
(Address of Principal Executive Offices)
|
|
28277
(Zip Code)
|
Amended
and Restated Outside Directors Stock Option Plan, as amended
(Full title of the plan)
James A. Parker
Interim Chief Financial Officer
MedCath Corporation
10720 Sikes Place, Suite 300
Charlotte, North Carolina 28277
(Name and address of agent for service of process)
(704) 708-6600
(Telephone number, including area code, of agent for service)
Copy to:
Thomas H. ODonnell, Jr. Esq.
Moore & Van Allen PLLC
100 North Tryon Street, Suite 4700
Charlotte, North Carolina 28202-4003
(704) 331-1000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
o
|
Accelerated filer
þ
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
o
|
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposed Maximum
|
|
|
Proposed Maximum
|
|
|
|
|
|
|
|
|
Amount To Be
|
|
|
Offering Price Per
|
|
|
Aggregate Offering
|
|
|
Amount of
|
|
|
Title of Securities to be Registered
|
|
|
Registered
|
|
|
Share
|
|
|
Price (1)
|
|
|
Registration Fee
|
|
|
Common stock, par value $0.01 per share
|
|
|
|
300,000
|
(1)
|
|
|
$
|
20.71
|
(2)
|
|
|
$
|
6,211,500
|
(2)
|
|
|
$
|
244.11
|
|
|
|
|
|
|
(1)
|
|
The 300,000 shares of common stock of the Registrant covered by this
Registration Statement are authorized and reserved for issuance under
the MedCath Corporation Outside Directors Compensation Plan, as
amended.
|
|
(2)
|
|
Estimated solely for the purpose of calculating the registration fee
pursuant to Rules 457(c) and (h)(1) under the Securities Act of 1933,
as amended (the Securities Act) and calculated, based on the average
of the high and low prices of our common stock on June 10, 2008, as
reported on the Nasdaq Global Select Market, which prices were $21.08
and $20.33, respectively.
|
This Registration Statement covers the registration of additional securities relating to an
employee benefit plan for which a Registration Statement on Form S-8 (File. No. 333-82432) was
filed by the Registrant with the Securities and Exchange Commission (the Commission) on February
8, 2002, the contents of which, including any amendments thereto, are incorporated by reference.
TABLE OF CONTENTS
EXPLANATORY NOTE
This Registration Statement covers an additional 300,000 shares of common stock, par value
$.01 per share (the Common Stock), of MedCath Corporation (the Company or the Registrant)
reserved for issuance under the Amended and Restated Outside Directors Stock Option Plan, as
amended (the Plan). Pursuant to Rule 428 promulgated under the Securities Act, the Company will
deliver a prospectus meeting the requirements of Part I of Form S-8 to all participants in the
Plan.
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The document(s) containing the information specified in this Part I will be sent or given to
participants as specified by Rule 428(b). In accordance with the rules and regulations of the
Commission, and the instructions to Registration Statement on Form S-8, such documents are not
being filed with the Commission either as part of this registration statement or as prospectuses or
prospectus supplements pursuant to Rule 424.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents, and any amendments thereto, filed by MedCath Corporation (the
Registrant)(File No. 000-33009) with the Commission are incorporated by reference in this
Registration Statement:
|
(a)
|
|
The Registrants Registration Statement on Form S-8 (File. No. 333-82432), including
exhibits thereto, is hereby incorporated by reference into this Registration Statement,
except as may be modified by the information set forth herein;
|
|
|
(b)
|
|
The Registrants Annual Report on Form 10-K for the fiscal year ended September 30,
2007;
|
|
|
(c)
|
|
The Registrants Quarterly Reports on Form 10-Q for the fiscal quarter ended December
31, 2007 and March 31, 2008;
|
|
|
(d)
|
|
The Registrants Quarterly Report on Form 10-Q/A for the fiscal quarter ended March 31,
2008;
|
|
|
(e)*
|
|
the Registrants Current Reports on Form 8-K filed on November 15, 2007, December 5,
2007, December 21, 2007, January 4, 2008, February 11, 2008, March 26, 2008, April 7, 2008,
April 23, 2008 and May 22, 2008; and
|
|
(f)
|
|
the section entitled Description of the Registrants Securities to be Registered
contained in our Registration Statement on Form 8-A (the Form 8-A)
filed with the Commission, pursuant to Section 12(g) of the Securities Exchange Act of 1934
(the Exchange Act), including all amendments and reports
updating such description.
|
|
|
|
*
|
|
All or any portion of any of the Registrants Current Reports on Form 8-K, which furnish
information pursuant to Item 2.02, Item 7.01 or Item 9.01 thereof, are not and shall not be deemed to
be incorporated by the reference herein.
|
All documents subsequently filed with the Commission by the Registrant pursuant to Sections 13(a),
13(c), 14 and 15(d) of the Exchange Act (other than those Current Reports on Form 8-K which
furnish information pursuant to Item 2.02, Item 7.01 or Item 9.01 of such report and exhibits
furnished in connection therewith) prior to the filing of a post-effective amendment, which
indicates that all securities offered herein have been sold or which deregisters all securities
then remaining unsold, shall be deemed to be incorporated by reference herein and to be part hereof
from the respective dates of filing of such documents.
The information incorporated by reference is considered to be part of this Registration
Statement and information that we file later with the Commission will automatically update and
supersede this information, as applicable. Any statement contained herein or in a document, all or
a portion of which is incorporated or deemed to be incorporated by reference herein, shall be
deemed to be modified or superseded for purposes of this Registration Statement to the extent that
a statement contained herein or in any other subsequently filed document modifies or supersedes
such statement. Any such statement so modified or superseded shall not be deemed, except as so
modified or amended, to constitute a part of this Registration Statement.
Item 4. Description of Securities.
Not applicable.
Item 5. Interest of Named Experts and Counsel.
Not applicable.
Item 6. Indemnification of Directors and Officers.
The Delaware General Corporation Law and the Registrants Amended and Restated Certificate of
Incorporation and Bylaws provide for indemnification of the Registrants directors and officers for
liabilities and expenses that they may incur in such capacities. In general, directors and
officers are indemnified with respect to actions taken in good faith in a manner reasonably
believed to be in, or not opposed to, the best interests of the Registrant, and with respect to any
criminal action or proceeding, actions that the indemnitee had no reasonable cause to believe were
unlawful. Reference is made to the Registrants Amended and Restated Certificate of Incorporation
and Bylaws filed as Exhibits 3.1 and 3.2, respectively, to the Form 8-A.
The Registrant has in effect a directors and officers liability insurance policy.
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits.
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
|
4.1
|
|
Amended and Restated Outside Directors Stock Option Plan (1)
|
|
|
|
4.2
|
|
Amendment to the Amended and
Restated Outside Directors Stock Option Plan (2)
|
|
|
|
5
|
|
Opinion of Moore & Van Allen, PLLC
|
|
|
|
23.1
|
|
Consent of Moore & Van Allen, PLLC (included in Exhibit 5)
|
|
|
|
23.2
|
|
Consent of Deloitte & Touche LLP
|
|
|
|
24
|
|
Power of Attorney (included as part of the signature page of this Registration Statement)
|
|
|
|
(1)
|
|
Incorporated by reference from the Registrants Quarterly Report on Form 10-Q for the quarter
ended March 31, 2002.
|
|
(2)
|
|
Incorporated by reference from the Registrants amended Quarterly Report on Form 10-Q/A for the
quarter ended March 31, 2008.
|
Item 9. Undertakings.
The undersigned Registrant hereby undertakes (i) to file, during any period in which offers or
sales are being made, a post-effective amendment to this Registration Statement to include any
material information with respect to the plan of distribution not previously disclosed in this
Registration Statement or any material change to such information in this Registration Statement;
(ii) that, for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof; and (iii) to remove from registration by means of a
post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.
The undersigned Registrant hereby undertakes that, for purposes of determining any liability under
the Securities Act, each filing of the Registrants annual report pursuant to Section 13(a) or
15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plans annual
report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this
Registration Statement shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to
directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions,
or otherwise, the Registrant has been advised that in the opinion of the Commission such
indemnification is against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than
the payment by the Registrant of expenses incurred or paid by a director, officer or controlling
person of the Registrant in the successful defense of any action, suit or proceeding) is asserted
by such director, officer or controlling person in connection with the securities being registered,
the Registrant will, unless in the opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities Act and will be
governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable
grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused
this Registration Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Charlotte in the State of North Carolina, on this 10 th day of June,
2008.
|
|
|
|
|
|
MEDCATH CORPORATION
|
|
|
By:
|
/s/ James A. Parker
|
|
|
|
James A. Parker
|
|
|
|
Interim Chief Financial Officer
|
|
|
POWER OF ATTORNEY AND SIGNATURES
We, the undersigned officers and directors of MedCath Corporation, hereby severally constitute
and appoint O. Edwin French and James A. Parker, and each of them,our true and lawful attorney,
with full power to him, to sign for us in our names in the capacities indicated below, any
amendments to this Registration Statement on Form S-8 (including post-effective amendments and any
additional registration statement pursuant to Rule 462(b) under the Securities Act, and to file the
same, with all exhibits thereto and other documents in connection therewith, with the Commission,
and generally to do all things in our names and on our behalf in our capacities as officers and
directors to enable MedCath Corporation, to comply with the provisions of the Securities Act hereby
ratifying and confirming our signatures as they may be signed by our said attorneys, or any of
them, to said Registration Statement and all amendments thereto.
Pursuant to the requirements of the Securities Act, this Registration Statement has been
signed by the following persons in the capacities and on the date indicated.
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ O. Edwin French
O. Edwin French
|
|
President and Chief Executive
Officer (Principal Executive
Officer)
|
|
June 10, 2008
|
|
|
|
|
|
/s/ James A. Parker
James A. Parker
|
|
Interim Chief Financial Officer
(Principal Financial Officer)
|
|
June 10, 2008
|
|
|
|
|
|
/s/ Lora Ramsey
Lora Ramsey
|
|
Vice President and Controller
(Principal Accounting Officer)
|
|
June 10, 2008
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ John T. Casey
John T. Casey
|
|
Chairman of the Board of Directors
|
|
June 10, 2008
|
|
|
|
|
|
/s/ Woodrin Grossman
Woodrin Grossman
|
|
Director
|
|
June 10, 2008
|
|
|
|
|
|
/s/ Edward R. Casas
Edward R. Casas
|
|
Director
|
|
June 10, 2008
|
|
|
|
|
|
/s/ Galen D. Powers
Galen Powers
|
|
Director
|
|
June 10, 2008
|
|
|
|
|
|
/s/ Paul B. Queally
Paul B. Queally
|
|
Director
|
|
June 10, 2008
|
|
|
|
|
|
/s/ Robert S. McCoy, Jr.
Robert S. McCoy
|
|
Director
|
|
June 10, 2008
|
|
|
|
|
|
/s/ Jacque J. Sokolov, MD
Jacque J. Sokolov
|
|
Director
|
|
June 10, 2008
|
|
|
|
|
|
/s/ Pamela G. Bailey
Pamela G. Bailey
|
|
Director
|
|
June 10, 2008
|
|
|
|
|
|
/s/ John B. McKinnon
John B. McKinnon
|
|
Director
|
|
June 10, 2008
|
INDEX TO EXHIBITS
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
|
5
|
|
Opinion of Moore & Van Allen, PLLC
|
|
|
|
23.1
|
|
Consent of Moore & Van Allen, PLLC (included in Exhibit 5)
|
|
|
|
23.2
|
|
Consent of Deloitte & Touche LLP
|
|
|
|
24
|
|
Power of Attorney (included as part of the signature page of this Registration Statement)
|
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jul 2023 to Jul 2024